Due to scheduled maintenance, PeopleSoft HCM will be unavailable from midnight Saturday, Dec. 20, to Sunday, Dec. 21, at 11 p.m. During this time, employees will be unable to view or update employee ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved aficamten to improve functional capacity and symptoms in adults with obstructive hypertrophic ...
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Myqorzo (aficamten, Cytokinetics) for treating adults ...
At UKG Aspire 2025, UKG announced its Workforce Intelligence Hub, designed to consolidate workforce data across HR, pay, and workforce management, and combine it with external benchmarks and other ...
Most people with HCM can participate in mild- to moderate-intensity exercise safely. When it comes to vigorous exercise and competitive sports, there may be a need for additional guidance from your ...
But if you have HCM, you can make a number of lifestyle choices to protect your heart health and enjoy a high quality of life. Heavy lifting is potentially risky when you’re living with HCM, because ...
MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...
CHARLOTTE, N.C. & STAMFORD, Conn.--(BUSINESS WIRE)--HCM II Acquisition Corp. (Nasdaq: HOND) (“HCM II”), a special-purpose acquisition company and Terrestrial ...
MADRID, Spain—For patients with hypertrophic cardiomyopathy (HCM), research presented today at the European Society of Cardiology (ESC) Congress 2025 demonstrated both the promise and the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results